TY - JOUR AU - Winkler, K. AU - Beron, G. AU - Delling, G. PY - 1988 DA - 1988// TI - Neoadjuvant chemotherapy of osteosarcoma: results of a randomized cooperative trial (COSS-82) with salvage chemotherapy based on histological tumor response JO - J Clin Oncol VL - 6 UR - https://doi.org/10.1200/JCO.1988.6.2.329 DO - 10.1200/JCO.1988.6.2.329 ID - Winkler1988 ER - TY - JOUR AU - Whelan, J. S. AU - Bielack, S. S. AU - Marina, N. PY - 2015 DA - 2015// TI - EURAMOS-1, an international randomised study for osteosarcoma: results from pre-randomisation treatment JO - Ann Oncol VL - 26 UR - https://doi.org/10.1093/annonc/mdu526 DO - 10.1093/annonc/mdu526 ID - Whelan2015 ER - TY - JOUR AU - Bielack, S. S. AU - Smeland, S. AU - Whelan, J. S. PY - 2015 DA - 2015// TI - Methotrexate, doxorubicin, and cisplatin (MAP) plus maintenance pegylated interferon alfa-2b versus MAP alone in patients with resectable high-grade osteosarcoma and good histologic response to preoperative MAP: first results oft he EURAMOS-1 good response randomized controlled trial JO - J Clin Oncol VL - 33 UR - https://doi.org/10.1200/JCO.2014.60.0734 DO - 10.1200/JCO.2014.60.0734 ID - Bielack2015 ER - TY - JOUR AU - Marina, N. M. AU - Smeland, S. AU - Bielack, S. S. PY - 2016 DA - 2016// TI - Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial JO - Lancet Oncol VL - 17 UR - https://doi.org/10.1016/S1470-2045(16)30214-5 DO - 10.1016/S1470-2045(16)30214-5 ID - Marina2016 ER - TY - JOUR AU - Bandyopadhyay, A. AU - Favours, E. AU - Phelps, D. A. PY - 2018 DA - 2018// TI - Evaluation of patritumab with or without erlotinib in combination with standard cytotoxic agents against pediatric sarcoma xenograft models JO - Pediatr Blood Cancer UR - https://doi.org/10.1002/pbc.26870 DO - 10.1002/pbc.26870 ID - Bandyopadhyay2018 ER - TY - JOUR AU - Ribatti, D. PY - 2014 DA - 2014// TI - The chick chorioallantoic membrane as a model for tumor biology JO - Exp Cell Res VL - 328 UR - https://doi.org/10.1016/j.yexcr.2014.06.010 DO - 10.1016/j.yexcr.2014.06.010 ID - Ribatti2014 ER - TY - JOUR AU - Ribatti, D. PY - 2016 DA - 2016// TI - The chick embryo chorioallantoic membrane (CAM). A multifaceted experimental model JO - Mech Dev VL - 141 UR - https://doi.org/10.1016/j.mod.2016.05.003 DO - 10.1016/j.mod.2016.05.003 ID - Ribatti2016 ER - TY - JOUR AU - Sys, G. AU - Bockstal, M. AU - Forsyth, R. PY - 2012 DA - 2012// TI - Tumour grafts derived from sarcoma patients retain tumour morphology, viability, and invasion potential and indicate disease outcomes in the chick chorioallantoic membrane model JO - Cancer Lett VL - 326 UR - https://doi.org/10.1016/j.canlet.2012.07.023 DO - 10.1016/j.canlet.2012.07.023 ID - Sys2012 ER - TY - JOUR AU - Balke, M. AU - Neumann, A. AU - Kersting, C. PY - 2010 DA - 2010// TI - Morphologic characterization of osteosarcoma growth on the chick chorioallantoic membrane JO - BMC Res Notes VL - 3 UR - https://doi.org/10.1186/1756-0500-3-58 DO - 10.1186/1756-0500-3-58 ID - Balke2010 ER - TY - JOUR AU - Sys, G. M. AU - Lapeire, L. AU - Stevens, N. PY - 2013 DA - 2013// TI - The in ovo CAM-assay as a xenograft model for sarcoma JO - J Vis Exp VL - 77 UR - https://doi.org/10.3791/50522 DO - 10.3791/50522 ID - Sys2013 ER - TY - JOUR AU - Balke, M. AU - Neumann, A. AU - Szuhai, K. PY - 2011 DA - 2011// TI - A short-term in vivo model for giant cell tumor of bone JO - BMC Cancer VL - 11 UR - https://doi.org/10.1186/1471-2407-11-241 DO - 10.1186/1471-2407-11-241 ID - Balke2011 ER - TY - JOUR AU - Marturano-Kruik, A. AU - Vilasante, A. AU - Yaeger, K. PY - 2018 DA - 2018// TI - Biomechanical regulation of drug sensitivity in an engineered model of human tumor JO - Biomaterials VL - 150 UR - https://doi.org/10.1016/j.biomaterials.2017.10.020 DO - 10.1016/j.biomaterials.2017.10.020 ID - Marturano-Kruik2018 ER -